Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 11, 2017

View Archived Issues

KIST presents novel drug candidate for Alzheimer's disease, KDS-2010

KemPharm reports preliminary data from phase I study of KP-415

First interim analysis of UNITY-NHL trial of TG-1101 and TGR-1202

PeptiDream, Shionogi and Sekisui to establish joint venture to manufacture special peptides

CARsgen's anti-Claudin18.2 CAR T-cell therapy begins phase I study

Cancer Research UK to collaborate with Biotecnol on development of novel immune-oncology drug

Radicava launched in U.S. for ALS

Mice bred to discover unknown genetic modifiers of familial Alzheimer's disease

NCI grant supports SignalRx's preclinical development of epigenetic-kinase inhibitors for cancer

Taiho Pharmaceutical begins enrolling patients in phase II study of TAC-302

Patient enrollment begins in phase I trial of CD33-CAR-T cell therapy in CD33-positive AML

FDA grants priority review to NDA for bictegravir/emtricitabine/tenofovir alafenamide in HIV

Takeda forms immuno-oncology research collaboration with Shattuck

New targets modifying tau pathology progression identified

Starpharma and Monash awarded funding from SIEF STEM+ Business Fellowship Program

EMERALD study bolsters darunavir, cobicistat, emtricitabine and tenofovir alafenamide fumarate

Novo Nordisk reviews key pipeline events of second quarter 2017

Chiasma reaches agreement with FDA on phase III trial of octreotide for acromegaly

Lundbeck reviews highlights of second quarter 2017

FDA accepts Achieve's IND for cytisine for smoking cessation

Yeda Research & Development patents protein LYRIC/transcription factor p65 interaction inhibitors

Beijing Marino Biotechnology describes a transgenic lymphocyte construct identifying EGFRvIII

Sumitomo Dainippon Pharma divulges new semaphorin-3A inhibitors

Guangzhou Institutes of Biomedicine and Health presents novel RORC antagonists

Novel orexin OX1 receptor antagonists discovered at C4X Discovery Holdings

Soin Neuroscience signs development agreement with Cleveland Diabetes Care for TV-1001sr

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...